Use of itaconate and its derivatives/analogues to induce hair growth
US-12527758-B2 · Jan 20, 2026 · US
This page is not indexed by search engines while we improve data quality.
Slusher Barbara patents
Slusher Barbara is listed as an inventor on 75 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Slusher Barbara |
| Total patents | 75 |
| First publication | Aug 10, 2017 |
| Latest publication | Jan 20, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Prodrugs for delivery of testosterone to the central nervous system
US-2026014170-A1 · Jan 15, 2026 · US
Prodrugs of 2-PMPA for healthy tissue protection during PSMA-targeted cancer imaging or radiotherapy
US-12508271-B2 · Dec 30, 2025 · US
Use of itaconate and its derivatives/analogues to induce hair growth
US-12496284-B2 · Dec 16, 2025 · US
Prodrugs of itaconate and methyl itaconate
US-12492160-B2 · Dec 9, 2025 · US
Dendrimer compositions and use in treatment of neurological and cns disorders
US-2025205369-A1 · Jun 26, 2025 · US
Gcpii inhibition for the treatment of sarcopenia and aging
US-2025064948-A1 · Feb 27, 2025 · US
Glutamine antagonists and uses thereof
US-12195419-B2 · Jan 14, 2025 · US
Small molecule neutral sphingomyelinase 2 (nSMase2) inhibitors
US-12195450-B2 · Jan 14, 2025 · US
Dopa and caffeic acid analogs as novel gcpii inhibitors
US-2024415800-A1 · Dec 19, 2024 · US
Recent patents
Latest publications not already listed above.
Methods for preventing and treating acute kidney injury
US-2024408114-A1 · Dec 12, 2024 · US
Prodrugs of itaconate and methyl itaconate
US-2024400498-A1 · Dec 5, 2024 · US
Dendrimer-glutamine antagonist conjugates and methods of use thereof
US-2024398962-A1 · Dec 5, 2024 · US
Use of itaconate and its derivatives/analogues to induce hair growth
US-2024398739-A1 · Dec 5, 2024 · US
nSMASE2 INHIBITOR PRODRUGS WITH ENHANCED ORAL AND BRAIN EXPOSURES
US-2024287108-A1 · Aug 29, 2024 · US
Prodrugs of 6-diazo-5-oxo-l-norleucine
US-2024246902-A1 · Jul 25, 2024 · US
INHIBITION OF nSMase FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION
US-2024115574-A1 · Apr 11, 2024 · US
Prodrugs of prostate specific membrane antigen (PSMA) inhibitor
US-11932664-B2 · Mar 19, 2024 · US
Prodrugs of glutamine analogs
US-11926640-B2 · Mar 12, 2024 · US
Glutamine antagonists for the treatment of cognitive deficits and psychiatric disorders
US-2024041900-A1 · Feb 8, 2024 · US
Prodrugs of 6-mercaptopurine
US-2024024347-A1 · Jan 25, 2024 · US
Prodrugs of hydroxamate-based GCPII inhibitors
US-11866394-B2 · Jan 9, 2024 · US
Compounds and their use for treating neuropathic pain
US-2024002395-A1 · Jan 4, 2024 · US
Decitabine analogs for immunological and oncological therapy
US-2023416294-A1 · Dec 28, 2023 · US
Dendrimer compositions and methods for drug delivery
US-2023372499-A1 · Nov 23, 2023 · US
2,6-dimethoxy-4-(5-phenyl-4-thiophene-2-yl-1H-imidazol-2-yl)-phenol (DPTIP) a small molecule inhibitor of neutral sphingomyelinase 2 (nSMase-2) for the treatment of neurodegenerative and oncologic diseases
US-11766423-B2 · Sep 26, 2023 · US
Methods for cancer and immunotherapy using prodrugs of glutamine analogs
US-11759444-B2 · Sep 19, 2023 · US
Inhibition of nSMase for the treatment of human immunodeficiency virus infection
US-11759466-B2 · Sep 19, 2023 · US
Mebendazole prodrugs with enhanced solubility and oral bioavailability
US-11712435-B2 · Aug 1, 2023 · US
Compositions and methods comprising dendrimers and therapeutic agents
US-2023218581-A1 · Jul 13, 2023 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Johns Hopkins | 76 |
| Inst Of Organic Chemistry And Biochemistry As Cr V V I | 21 |
| Ustav Organicke Chemie A Biochemie Av Cr V V I | 7 |
| Ustav Organicke Chemie A Biochemie Av Hacek Over C R V V I | 6 |
| Icahn School Med Mount Sinai | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.